SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-130074
Filing Date
2021-04-26
Accepted
2021-04-26 06:05:00
Documents
8
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d127916ddef14a.htm DEF 14A 344921
2 GRAPHIC g127916g001_1.jpg GRAPHIC 2447
3 GRAPHIC g127916g001ga.jpg GRAPHIC 2010
4 GRAPHIC g127916g001gb.jpg GRAPHIC 1585
5 GRAPHIC g127916g001gc.jpg GRAPHIC 1058
6 GRAPHIC g127916g002_1.jpg GRAPHIC 952
7 GRAPHIC g127916g002_2.jpg GRAPHIC 1045
8 GRAPHIC g127916g84s61.jpg GRAPHIC 26533
  Complete submission text file 0001193125-21-130074.txt   390613
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39269 | Film No.: 21851427
SIC: 2834 Pharmaceutical Preparations